12/4/2025Lynk Receives FDA IND Approval for Its Brain-Penetrant Allosteric TYK2...

12/4/2025Simcere Secures Greater China Rights to Vigonvita's VV116 Dry Suspens...

12/4/2025China's Healthcare Costs Shift to Individuals as Government Share Decl...

12/3/2025WuXi Biologics Extends Global CRDMO Network to Qatar

12/3/2025L&L Bio Completes Series B++ Financing to Advance Bispecific and Trisp...

12/3/2025CDE Seeks Comments on Draft Guidelines Defining Major Deficiencies in ...

12/2/2025Lynk Pharma Files for Hong Kong IPO to Accelerate JAK-STAT and TYK2 Dr...

12/2/2025Proviva Raises Over US$30M to Advance Next-Gen Cancer Immunotherapies

12/2/20253SBio Seeks HK$3.12B in HK Share Placement to Accelerate Global Drug D...

12/2/2025Fangzhou and Tencent Launch Full-Stack AI Platform to Transform Chroni...

12/2/2025China Used to Be a Cash Cow for Western Companies. Now It's a Test Lab...

12/2/2025NHC Releases 2024 China Health Statistics Bulletin

12/2/2025China Launches National Drug Price Registration System to Propel Marke...

12/1/2025MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Inv...

12/1/2025Innovent's Pecondle Wins China Approval as First Homegrown IL-23p19 An...

12/1/2025Lion TCR Partners With SIAT to Advance Universal Cell Therapy for Soli...

12/1/2025New ADC Shows Broad Antitumor Activity With Strong Bystander Effect

12/1/2025SystImmune Nets $250 Million Milestone from BMS After First‑Patient ...

12/1/2025PhIIC Report Highlights China's API Industry Rebound as Adjustment Cyc...

11/28/2025BeOne Secures USFDA Priority Review for Sonrotoclax

11/28/2025Pierre Fabre Expands Investment in China Thru New Sinopharm Partnersh...

11/28/2025China Expands Grassroots Healthcare Access with More Doctors, Mobile S...

11/28/2025WakerBio Raises ~CNY 100M to Accelerate Global CGT Safety and Clinical...

11/28/2025Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...

11/28/2025Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...

11/28/2025Recent Executive Moves

11/28/2025LEK: China's Clinical Trial Sector Enters a New Phase of Innovation an...

11/27/2025MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...

11/27/2025Sugemalimab Wins European Approval for Stage III NSCLC

11/27/2025CSPC's JMT206 Wins Green Light for First-in-Human Trials in China

Page:1/803 Total number of articles:24077: [First][<<] [1] [2] [3] [4] [5] [>>] [End]